Home > Information
Information
- Oct. 12, 2018
- Cancer Registration Training at Cambodia and Viet Nam
- Oct. 1, 2018
- National Cancer Center Japan and Maruho Enter License Agreement and Research Collaboration Agreement for a Novel Analgesic for Stomatitis in Cancer Treatment
- Sep. 18, 2018
- Visit to Norman E. Sharpless MD and his delegation at the National Cancer Institute
- Sep. 15, 2018
- Projected Cancer Statistics, 2018
- Aug. 22, 2018
- National Cancer Center Japan - IARC Seminar 4
- Aug. 8, 2018
- Dr Masaaki Ito appointed Honorary Professor at China-Japan Friendship Hospital
- Aug. 2, 2018
- Organization Chart Updated
- Jun. 27, 2018
- Development of an integrated CRISPRi targeting ΔNp63 for treatment of squamous cell carcinoma
- Jun. 1, 2018
- NCC Establishes Center for Cancer Genomics and Advanced
Therapeutics (C-CAT) to Aggregate and Manage Information on
Cancer Genomic Medicine and Promote Its Use - May 28, 2018
- New Agreement with National Cancer Hospital, Vietnam
- May 7, 2018
- National Cancer Center and Carna Biosciences Announce Research Collaboration for new drug discovery
- Apr. 23, 2018
- National Cancer Center – IARC Seminar 3
- Apr. 3, 2018
- National Cancer Center Hospital offers Next Generation Sequencing tests as ‘Advanced Medical Care’
Towards coverage under national health insurance system - Apr. 3, 2018
- Advanced Medical Care Approval Received for Multiplex Gene Panel Testing
to Advancing Personalized Medicine - Mar. 30, 2018
- NCC joins China and Korea at the first 3 national cancer centers’ workshop
- Mar. 19, 2018
- Cancer Registration Seminar in Indonesia
- Mar. 13, 2018
- SCRUM-Japan GI-SCREEN Aims for Realizing of Cancer Precision Medicine Utilizing Liquid Biopsy by Analyzing Comprehensive Cancer Genome Alterations in Blood
- Mar. 9, 2018
- WHO Classification of Tumours Series appoints Dr Ochiai to Editorial Board
- Feb. 14, 2018
- A secondary RET mutation in the activation loop conferring
resistance to vandetanib through allosteric effects - Feb. 5, 2018
- Maestro Chung Visit
- Jan. 23, 2018
- Precise cancer risk estimation based upon measurement of mutations and aberrant DNA methylation accumulated in normal tissues
association between the accumulation and life style - Dec. 22, 2017
- T. Matsuda takes office of International Association of Cancer Registries President
- Dec. 18, 2017
- Cancer Statistics in Japan; Table download
- Dec. 14, 2017
- National Cancer Center - IARC Seminar 2
- Dec. 5, 2017
- NCC signs comprehensive MoU with WHO/IARC
- Nov. 27, 2017
- Asian Early Phase Oncology Drug Development Consortium Formed
- Nov. 21, 2017
- New Agreement with National Cancer Center, Indonesia
- Nov. 14, 2017
- Lithuanian Health Minister Visit
- Oct. 30, 2017
- Cancer Statistics in Japan; Table download
- Oct. 27, 2017
- Collaborative Research on Fully-personalized Cancer Neoantigen Vaccine
- Oct. 27, 2017
- Projected Cancer Statistics, 2017
- Oct. 26, 2017
- National Cancer Center - IARC Seminar 1
- Oct. 16, 2017
- Commencement of Collaborative Research on Measurement of Exosomes in Blood from Cancer Patients
- Aug. 3, 2017
- Japan-Singapore lead international research in discovering potential targeted treatments for biliary tract cancer
- Aug. 1, 2017
- On-Table Adaptive Radiation Therapy
- Jul. 31, 2017
- The MASTER KEY PROJECT
Genomic medicine in Rare Cancers:
A collaboration between the industry and academia - Jul. 21, 2017
- Cancer Registration Seminar in Myanmar
- Jul. 11, 2017
- Cancer Statistics in Japan; Table download
- Jun. 26, 2017
- A novel biomarker for development of a new screening technique for early-stage pancreatic cancer and precancerous conditions associated with risk of pancreatic malignancy - experimental screening in Kagoshima Prefecture
- Jun. 16, 2017
- National Cancer Center hosts Iranian Delegation
- May 30, 2017
- WHO/International Agency for Research on Cancer establishes National Cancer Center as Global Initiative for Cancer Registry Development Collaborating Centre
- Apr. 27, 2017
- Elucidation of the mechanism of MLL-rearranged leukemia Use of two molecularly targeted drugs as novel therapy
- Mar. 1, 2017
- Commencement of Phase 1 Trial for the Mutant IDH1 Inhibitor (DS-1001)Targeting Malignant Brain Tumors
- Feb. 28, 2017
- Malignant extracellular vesicles derived from ovarian cancer cells facilitate peritoneal dissemination, and the vesicles can be promising targets for improving patient outcomes.
- Feb. 21, 2017
- Signing MOU with the National Cancer Research Institute (UK)